PMID- 20675200 OWN - NLM STAT- MEDLINE DCOM- 20110422 LR - 20131121 IS - 1528-8447 (Electronic) IS - 1526-5900 (Linking) VI - 12 IP - 1 DP - 2011 Jan TI - Progesterone prevents allodynia after experimental spinal cord injury. PG - 71-83 LID - 10.1016/j.jpain.2010.04.013 [doi] AB - Chronic pain after spinal cord injury represents a therapeutic challenge. Progesterone, a neuroprotective steroid, has been shown to modulate nociceptive thresholds, whereas its effect on neuropathic pain needs to be further explored. In this study, we evaluated whether progesterone could ameliorate pain-associated behaviors in animals subjected to a spinal cord hemisection. The development of mechanical and cold allodynia was assessed in injured male rats treated with daily injections of progesterone or vehicle. The expression of N-methyl-D-aspartate receptor (NMDAR) subunits, protein kinase C gamma (PKCgamma), preprodynorphin (ppD), and kappa opioid receptor (KOR), key players in chronic pain mechanisms, was determined in the dorsal spinal cord. Twenty-eight days after injury, all vehicle-treated animals presented allodynic behaviors and a marked increase in NMDAR subunits, PKCgamma, and ppD mRNA levels, with no changes in KOR mRNA levels. Progesterone prevented the development of mechanical allodynia and reduced the painful responses to cold stimulation. In correlation with the attenuation of pain behaviors, the steroid prevented NMDAR subunits and PKCgamma mRNAs upregulation, did not modify the elevated ppD mRNA levels, but increased KOR expression. In conclusion, progesterone modulates neuropathic pain after spinal cord injury, creating a favorable molecular environment that may decrease spinal nociceptive signaling. PERSPECTIVE: The present study suggests that progesterone administration could represent an interesting strategy to modulate neuropathic pain circuits after spinal cord injury. Further studies are needed to investigate the potential progesterone receptors involved in these actions. CI - Copyright (c) 2011 American Pain Society. Published by Elsevier Inc. All rights reserved. FAU - Coronel, Maria F AU - Coronel MF AD - Laboratorio de Bioquimica Neuroendocrina, Instituto de Biologia y Medicina Experimental, CONICET, Buenos Aires, Argentina. FAU - Labombarda, Florencia AU - Labombarda F FAU - Villar, Marcelo J AU - Villar MJ FAU - De Nicola, Alejandro F AU - De Nicola AF FAU - Gonzalez, Susana L AU - Gonzalez SL LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100802 PL - United States TA - J Pain JT - The journal of pain JID - 100898657 RN - 0 (NR2A NMDA receptor) RN - 0 (NR2B NMDA receptor) RN - 0 (Progestins) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (Receptors, Opioid, kappa) RN - 0 (Tuberculin) RN - 4G7DS2Q64Y (Progesterone) RN - EC 2.7.1.- (protein kinase C gamma) RN - EC 2.7.11.13 (Protein Kinase C) SB - IM MH - Animals MH - Disease Models, Animal MH - Functional Laterality MH - Gene Expression Regulation/drug effects MH - Hyperalgesia/*etiology/*prevention & control MH - Male MH - Neuralgia/etiology/prevention & control MH - Pain Measurement MH - Pain Threshold/*drug effects MH - Progesterone/*therapeutic use MH - Progestins/*therapeutic use MH - Protein Kinase C/genetics/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, N-Methyl-D-Aspartate/genetics/metabolism MH - Receptors, Opioid, kappa/genetics/metabolism MH - Spinal Cord Injuries/*complications MH - Tuberculin/genetics/metabolism EDAT- 2010/08/03 06:00 MHDA- 2011/04/26 06:00 CRDT- 2010/08/03 06:00 PHST- 2010/01/09 00:00 [received] PHST- 2010/03/18 00:00 [revised] PHST- 2010/04/29 00:00 [accepted] PHST- 2010/08/03 06:00 [entrez] PHST- 2010/08/03 06:00 [pubmed] PHST- 2011/04/26 06:00 [medline] AID - S1526-5900(10)00533-X [pii] AID - 10.1016/j.jpain.2010.04.013 [doi] PST - ppublish SO - J Pain. 2011 Jan;12(1):71-83. doi: 10.1016/j.jpain.2010.04.013. Epub 2010 Aug 2.